To view this email as a web page, click here.

 
EULAR Treatment Recommendations for the Blood Clotting Disorder APS
The European League Against Rheumatism (EULAR) has prepared the first set of treatment guidelines for antiphospholipid syndrome (APS), a rare systemic autoimmune disorder associated with blood clots that can be life-threatening. Sometimes known as Hughes syndrome, there is little research on the condition and little agreement on its clinical criteria. As a result, treatment approaches may differ from doctor to doctor. APS can lead to stroke, heart attack, kidney damage, deep vein thrombosis, pulmonary embolism, recurrent early miscarriages, premature birth due to eclampsia and late pregnancy losses.
Read more
 
 
  • Ultrasound on Point as Predictor of Cardiovascular Risk in Psoriatic Disease
  • Image IQ: Erythematous Rash
  • An Increased Risk for Blood Clots in Ankylosing Spondylitis
  • Guideline Helps Physicians Reduce Blood Clots after Hip and Knee Replacement
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.